Clevudine | 11-076

Clevudine | 11-076 | Gentaur UK, US & Europe Distribution

BNR: Chemical

Predicted Molecular Weight: 260, 2

Physical State: Lyophilized

Storage Condition: Short Term Storage: +4C. Long Term Storage: -20C. Handling Advice: Keep cool and dry. Use/Stability: Stable for at least 2 years after receipt when stored at -20C.

Alternate Name: Levovir; L-FMAU; 2'-Fluoro-5-methyl-β-L-arabinofuranosyl-uracil

Background: Clevudine is a synthetic pyrimidine nucleoside analog antiviral agent with activity against hepatitis B virus (HBV) and Epstein-Barr virus (EBV) . Intracellularly, clevudine is phosphorylated to its active metabolites, clevudine monophosphate and triphosphate. The triphosphate metabolite competes with thymidine for incorporation into viral DNA, thereby causing DNA chain termination and inhibiting the function of HBV DNA polymerase and reverse transcriptase, consequently blocking the viral replication. It also blocks the DNA supply of the virus into the nucleus, reducing the amount of cccDNA by 20-100 times. Potentially useful for the treatment of the SARS-CoV-2 (COVID-19) infection, acting as a potent inhibitor of the RdRp protein.

Disclaimer: This product is for research use only.

Purity: greater than or equal to 98% (HPLC)

Formula: C10H13FN2O5

Source: N/A

Solubility: Soluble in water (30mg/ml) or DMSO (20mg/ml) .

InChi Key: GBBJCSTXCAQSSJ-XQXXSGGOSA-N

Smiles: O[C@H]1[C@H] (CO) O[C@] ([H]) (N2C=C (C) C (NC2=O) =O) [C@@H]1F

RTECS: N/A

Identity: Determined by 1H-NMR.

Merck Index: N/A